My Hairloss Journey (4 years of treatment, early 20s)
    Progress Pictures 1/26/2024

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg daily 3 years
    💧 Minoxidil (topical) 3 years
    💊 Dutasteride (oral) 0.5mg 3x weekly 1 year
    💊 Dutasteride (oral) 0.5mg daily
    💊 Dutasteride (oral) 1mg daily
    💊 Dutasteride (oral) 0.5mg 2x weekly
    💊 Oral Minoxidil (oral) 2.5mg daily
    the tone is 😐 neutral with impressive results.

    Other terms

    A user shared their 4-year hair loss journey, starting with finasteride and minoxidil, then adding dutasteride and oral minoxidil, which improved their hair. They are now considering RU58841 and a hair transplant in the future.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research CLINICAL UPDATES IN HAIR

      19 citations , January 1997 in “Dermatologic Clinics”
      This chapter reviews various antiandrogens and androgen inhibitors, detailing their mechanisms, uses, and side effects, with a focus on spironolactone, finasteride, dutasteride, and oral contraceptives.

      research Тіе Modern treatment of androgenetic alopecia

      February 2017 in “Vestnik dermatologii i venerologii”
      This review examines the molecular mechanisms and current treatment options for androgenetic alopecia, highlighting potential future therapies but providing no new experimental findings.

      research Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique

      March 2025 in “HAL (Le Centre pour la Communication Scientifique Directe)”
      This thesis investigates the underlying mechanisms and treatment options for androgenetic alopecia, highlighting the molecular roles of androgens and genetic predispositions, and evaluates current and emerging therapies, such as PROTACs and Janus Kinase inhibitors, to enhance patient management.

      research Therapeutic strategies for treating hair loss

      42 citations , March 2006 in “Drug Discovery Today: Therapeutic Strategies”
      This article discusses the need for rational strategies in developing hair loss drugs targeting specific events in hair follicle cycling, reporting no clinical findings but emphasizing the importance of understanding molecular controls.